TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,138 Cr | ₹1,911 Cr | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr |
What is the latest Profit After Tax of TORRENT PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹2,138 Cr |
| Mar2025 | ₹1,911 Cr |
| Mar2024 | ₹1,656 Cr |
| Mar2023 | ₹1,245 Cr |
| Mar2022 | ₹777 Cr |
How is Profit After Tax of TORRENT PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,138 Cr | 11.87 | |
| Mar2025 | ₹1,911 Cr | 15.39 | |
| Mar2024 | ₹1,656 Cr | 33.02 | |
| Mar2023 | ₹1,245 Cr | 60.22 | |
| Mar2022 | ₹777 Cr | - | |
Compare Profit After Tax of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹169,805.7 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹105,174.0 Cr | 0.6% | 7% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.5% |
11.3% |
49.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses